Filing Details
- Accession Number:
- 0001209191-13-017097
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-18 14:37:16
- Reporting Period:
- 2013-03-15
- Filing Date:
- 2013-03-18
- Accepted Time:
- 2013-03-18 14:37:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178879 | Amicus Therapeutics Inc | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1247015 | J Sol Barer | C/O Amicus Therapeutics 1 Cedar Brook Drive Cranbury NJ 08512 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-03-15 | 25,000 | $3.40 | 45,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $3.30 to $3.50. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.